The FDA has approved Sisnos’s continuous glucose monitoring (CGM) system for consumer use beyond diabetes management, ...

The Signos Glucose Monitoring System is a mobile device application that receives data from an OTC integrated continuous ...

The FDA cleared the first glucose monitoring system specifically designed for weight management from Signos, providing a new ...

The FDA approved the first over-the-counter glucose monitoring system designed to help with weight management. Developed by health technology company Signos, the system combines the Stelo by Dexcom ...

Signos Inc. landed U.S. FDA clearance for its over-the-counter glucose monitoring system, which combines Dexcom Inc.'s ...

Any patient can access Signos' system, which uses an AI platform and an off-the-shelf continuous glucose monitor, or CGM, ...

Launched in 2018, Signos combines continuous glucose information with an AI-enhanced app to offer revolutionary continuous data and recommendations designed to drive healthy and sustained weight loss.

Signos’s glucose-tracking system uses AI and real-time data to guide healthier habits—no prescription required.

Signos, a metabolic health platform that utilizes a unique AI-engine with a continuous glucose monitor (CGM) to offer real-time data and recommendations for healthy weight management, has ...

Signos, a metabolic health platform that utilizes a unique AI-engine with a continuous glucose monitor (CGM) to offer real-time data and recommendations for healthy weight management, has ...

The FDA on Wednesday approved the first-ever glucose monitoring system specifically for weight loss from the startup Signos, establishing a new option for Americans to manage their weight. The Signos ...

The Signos platform will help develop personalized answers to basic questions like what to eat, when to eat and what exercises help encourage weight loss. At the heart of the system is Dexcom ‘s ...